Consistent with the observations in AKI patients, CKD patients exhibited reduced expression of circAASS, PPARGC1A/PGC-1α, and PINK1, along with elevated ROS levels in TECs (Figure 9(J-N)). Here, PPARGC1A is linked to chronic kidney disease.